Clinical stage company developing the next-gen Photodynamic Therapy (PDT), called Photosoft, for the treatment of a range of cancers & infectious diseases
Melbourne, Australia and HK
Joined December 2012
- Tweets174
- Following127
- Followers181
- Likes0
We are excited to be profiled by Stockhead in The Australian with the publication showcasing our promising Photosoft technology in fighting cancers. Click here to read more theaustralian.com.au/busines… #stockstofocus #ASX #Biotechnology #investing #Oncology #CancerResearch
Invion Limited retweeted
Solid safety data from @InvionLimited's Ph2 prostate cancer trial very encouraging vs potential side effects from radiotherapy/surgery (urinary incontinence, bowel & erectile dysfunction, infertility) investors.inviongroup.com/an… #CancerResearch #Oncology #smallcap #StocksInFocus
Following our positive Phase 2 Prostate Cancer Trial results, many have asked how Photosoft works. This 1 minute animation explains the mechanism of action #CancerResearch #ASX #biotech #StocksInFocus #Stocks #stockinvesting #SmallCaps
Invion Limited retweeted
Invion’s (#ASX: $IVX) INV043 candidate demonstrates positive results in Phase II prostate cancer trial.
smallcaps.com.au/invion-inv0… @InvionLimited
Webinar where Invion's CEO, Thian Chew, spoke about the successful Ph 2 prostate cancer results, the Ph 1/2 skin cancer trial and what these mean for Invion in the near-term. youtube.com/watch?v=QttqRDHv…
#investing #investments #cancerresearch #ASX #stockstowatch #smallcaps #biotech
Results from Ph 2 prostate cancer trial using INV043 showed it to be safe & well tolerated by patients, 40% showed a positive response using RECIST 1.1 (10% complete regression) & 44% negative on PSMA-PET. investors.inviongroup.com/an… #asx #smallcaps #CancerResearch #investing
Invion eyes multiple applications and new markets for next-generation photodynamic therapy #investments #ASX #biotech #Covid_19 #shares #stocks
smallcaps.com.au/invion-grou…